Sanofi Elevates Manuela Buxo to Lead Specialty Care Unit on March 1
Manuela Buxo will replace Brian Foard as head of Sanofi’s Specialty Care Global Business Unit on March 1, succeeding Foard who led the division for nearly nine years and departs on February 28. Buxo has directed Dupixent’s worldwide strategy for two years and brings over 20 years of healthcare experience.
1. Executive Leadership Change
On February 17 Sanofi announced that Manuela Buxo will succeed Brian Foard as head of its Specialty Care Global Business Unit effective March 1. Brian Foard will depart on February 28 after leading the division for nearly nine years.
2. Buxo's Background and Achievements
Buxo currently oversees the Global Immunology Alliance Franchise and has directed the global Dupixent strategy for two years, contributing to its market expansion. Her more than 20 years in healthcare include Specialty Care roles in Europe and global franchise management positions.
3. Strategic Implications for Specialty Care
Under Foard's tenure the Specialty Care unit grew significantly, driven by Dupixent’s launch, and Buxo’s deep immunology expertise may support continued growth and alignment with Sanofi’s global franchise objectives.